These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4380607)

  • 1. Utilization of hydrophilic gums for the control of drug release from tablet formulations. I. Disintegration and dissolution behavior.
    Huber HE; Dale LB; Christenson GL
    J Pharm Sci; 1966 Sep; 55(9):974-6. PubMed ID: 4380607
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of hydrophilic gums for the control of drug substance release from tablet formulations. II. Influence of tablet hardness and density on dissolution behavior.
    Huber HE; Christenson GL
    J Pharm Sci; 1968 Jan; 57(1):164-7. PubMed ID: 5652122
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of critical manufacturing and formulation variables for a hydrophilic matrix tablet formulation using an in vitro discriminatory dissolution method.
    Stark P; Kinahan A; Cunningham S; Butler J; O'Hara T; Dunne A; Connolly J; Devane J
    Adv Exp Med Biol; 1997; 423():137-47. PubMed ID: 9269489
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORRELATION OF WATER ABSORPTION WITH TABLET DISINTEGRATION TIME.
    BILLUPS NF; COOPER BF
    Am J Pharm Sci Support Public Health; 1964; 136():25-37. PubMed ID: 14114385
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets.
    Amaral MH; Lobo JM; Ferreira DC
    AAPS PharmSciTech; 2001 Apr; 2(2):E6. PubMed ID: 14727881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
    Dadarwal SC; Madan S; Agrawal SS
    Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
    Abdelkader H; Abdalla OY; Salem H
    AAPS PharmSciTech; 2007 Nov; 8(4):E100. PubMed ID: 18181521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native and microwave-modified Terminalia mantaly gums as sustained-release and bioadhesive excipients in naproxen matrix tablet formulations.
    Odeniyi MA; Oyedokun BM; Bamiro OA
    Polim Med; 2017; 47(1):35-42. PubMed ID: 29160627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of 3D Printed Molds to Cast Tablets with a Designed Disintegration Profile.
    Ajmal A; Meskarzadeh A; Genina N; Hirschberg C; Boetker JP; Rantanen J
    AAPS PharmSciTech; 2019 Feb; 20(3):127. PubMed ID: 30809745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.